OpenAI Takes the Lead in AI IPO Race Confidential Filing Expected Soon Charter Communications Enhances Offer for Liberty Broadband in Buyout Deal From Banking to the Boardroom Shyam Srinivasans Better Never Stops Distils a Career of Resilience Trump Intensifies Pressure on Bank of America and JPMorgan Over Alleged AntiConservative Banking Practices UK Police Chiefs Push for Social Media Ban on Under16s Over Safety Risks Signos Secures 20M in Funding to Expand AIPowered Glucose Monitoring for Weight Loss CHE Q1 2026 Earnings EPS Beats Estimates by 55 LGI Homes Q1 2026 Earnings Stellar EPS Beat Drives DoubleDigit Surprise SLDE Q1 2026 Earnings Strong Earnings Beat Highlights Improving Underwriting Performance Marriott International Q1 2026 Earnings EPS Beats Estimates by 546 Shares Edge Lower WPC Q1 2026 Earnings EPS Surges Past Estimates Despite Slight Stock Decline Service Properties Trust Q1 2026 Earnings Net Loss Widens Sharply Shares Edge Higher Despite Miss Par Pacific PARR Holds Steady Near Support After Modest Decline Yorkville Acquisition Corp Warrant MCGAW Holds Steady at 036 Amid RangeBound Trading Voya Emerging Markets High Income Dividend Equity Fund IHD Edges Higher as Income Seekers Take Notice NNN REIT Inc NNN Holds Steady Near Support Awaiting Catalyst Honda Motor HMC Edges Higher Amid Modest Gains Key Levels in Focus US Stocks Reach New Highs as AI Rally Shows Signs of Cooling Aditxt Inc ADTX Q3 2025 Earnings Significant Loss Per Share and No Revenue Amid Sharp Stock Decline STRK Preferred Stock Sees Minor Decline as Investors Assess Yield and Resistance Levels ROST Q1 2026 Earnings Strong EPS Beat Drives Stock Rally Presidio Property Trust Q3 2023 Earnings Net Loss Reported Amidst Market Challenges GH Q1 2026 Earnings EPS Beats Estimates Amidst Focus on Precision Oncology PAC Q1 2026 Earnings EPS Surges Past Estimates Stock Edges Lower PMTS Q1 2026 Earnings EPS Falls Short of Estimates Amid Challenging Conditions KRG Q1 2026 Earnings EPS Miss of 6377 Raises Questions Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development